Viewing Study NCT00335465



Ignite Creation Date: 2024-05-05 @ 4:52 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00335465
Status: COMPLETED
Last Update Posted: 2009-12-07
First Post: 2006-06-08

Brief Title: Lantus Effect on Myocardial Glucose Metabolism in T2
Sponsor: Sanofi
Organization: Sanofi

Study Overview

Official Title: Pilot Study for the Evaluation of the Effects of Insulin Treatment on Myocardial Function Perfusion and Glucose Metabolism in Patients With Primary Left Ventricular Dysfunction and Type 2 Diabetes
Status: COMPLETED
Status Verified Date: 2009-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective of the present study is to assess changes of myocardial glucose uptake MGU during clamp studies using positron emission tomography PET scanning in patients with type 2 diabetes and idiopathic left ventricular dysfunction LVD

The secondary objectives of the study are assessment of changes of myocardial microcirculation at rest and during adenosine stimulation using PET assessment of changes in myocardial structure and function evaluated by magnetic resonance imaging MRI assessment of glycaemic control by measurement of HbA1c fasting blood glucose and insulin levels assessment of safety adverse event profile laboratory data
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
EUDRACT 2004-002729-34 None None None